Evidence map›Paper›PMID 40244459›Full record

ArticleInternational journal of molecular sciences2025

Merging High-Throughput, Amplicon-Based Second and Third Generation Sequencing Data: An Integrative and Modular Data Analysis Framework for Haplotype Prediction and Output Evaluation.

Sylvia Mink, Christian Attenberger, Yannik Busch, Johanna Kiefer, Wolfgang Peter, Janne Cadamuro, Tim A Steiert, Andre Franke, Christoph Gassner

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sylvia MinkCentral Medical Laboratories, Carinagasse 41, 6800 Feldkirch, Austria.ORCID 0000-0001-7615-6544
Christian AttenbergerFaculty of Medical Science, Private University in the Principality of Liechtenstein, 9495 Triesen, Liechtenstein.
Yannik BuschStefan-Morsch-Stiftung, 55765 Birkenfeld, Germany.ORCID 0000-0001-6261-6853
Johanna KieferStefan-Morsch-Stiftung, 55765 Birkenfeld, Germany.
Wolfgang PeterStefan-Morsch-Stiftung, 55765 Birkenfeld, Germany.ORCID 0009-0003-3217-5163
Janne CadamuroDepartment of Laboratory Medicine, Paracelsus Medical University Salzburg, 5020 Salzburg, Austria.ORCID 0000-0002-6200-9831
Tim A SteiertInstitute of Clinical Molecular Biology, Christian-Albrechts-University and University Medical Center Schleswig-Holstein, 24118 Kiel, Germany.ORCID 0000-0002-0125-1173
Andre FrankeInstitute of Clinical Molecular Biology, Christian-Albrechts-University and University Medical Center Schleswig-Holstein, 24118 Kiel, Germany.
Christoph GassnerInstitute of Translational Medicine, Private University in the Principality of Liechtenstein, 9495 Triesen, Liechtenstein.ORCID 0000-0002-6580-7855

Funding

Dr. Karl Landsteienr Fonds NAStefan-Morsch-Stiftung, Birkenfeld, Germany NA
6 · The paper itself

Abstract

Despite providing highly accurate results, the short reads generated by second generation sequencing have major limitations in mapping complex genomic regions. Longer reads can resolve these issues and additionally phase distant variants. The third generation sequencing platform ONT currently achieves the longest sequencing reads but falls short in sequencing accuracy. Additionally, deriving phased haplotypes from amplicon-based NGS data remains a complex and time-consuming task that requires extensive bioinformatic expertise. We constructed an integrative, open-access modular data-analysis framework that allows for automated processing of high-throughput sequencing data from both second (Illumina) and third generation (ONT) sequencing platforms, combining the strengths of both technologies. Variant information is automatically evaluated and color-coded for discrepancies. Haplotypes are listed by frequency. All parts of the framework can be used independently. The framework's performance was validated using synthetic and tested with real-life data by analyzing partly homologous

Indexed as

HaplotypesHigh-Throughput Nucleotide SequencingSequence Analysis, DNAComputational BiologyData AnalysisHumansPolymorphism, Single Nucleotideamplicon-baseddata analysis frameworkhaplotypesIlluminanext-generation sequencingONTphasingraw datathird generation sequencing

Identifiers

PMID40244459
PMCPMC11990026

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.